Bio-Rad Laboratories (BIO_B) Stock Forecast: StockMap's 2-Week Call

BIO_B stock forecast: StockMap's model leans Outperform on Bio-Rad Laboratories for the two weeks after the Nov 19 close, toward BIO_B doing better than the growth index. It is a lean inside the no-call band, not a call, and not a price target. Right in 5 of 6 two-week windows on BIO_B since Aug 21; by chance, a call on the same dates was right 67% of the time.

Bio-Rad Laboratories last closed at $389.98, +0.00% on the session.

Against the IVW growth benchmark the position is +2.33% over the forecast window.

Bio-Rad Laboratories' market cap is $1.97B as of November 19, 2026.

Leans up ↗: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is 21 (too close to call).

Where BIO_B sits: sized by market cap, coloured by the day's move.

The read is built from 15 underlying insights — 9 bullish and 6 bearish.

Agreement across those insights is 60%.

33 daily calls for BIO_B so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Bio-Rad Laboratories in the 82nd percentile on valuation and the 70th percentile on return on equity, where 100 is best.

Bio-Rad Laboratories is classified under Health Care / Life Sciences Tools & Services.

StockMap tracks Bio-Rad Laboratories as the 25th largest of the 42 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 23 Neutral, 16 Moderate Outperform and 3 Moderate Underperform.

On that composite Bio-Rad Laboratories ranks 15th of 42 in the group, against a group median of +0.13.

Other Health Care stocks

Research and education, not investment advice. The calls on this page come from StockMap's automated model, run on the close of November 19, 2026, and are the same for every reader. Calls are graded in public, misses included: how calls are graded, and the record. Who makes the calls and who pays for the site: Disclosures.

Bio-Rad Laboratories (BIO_B) — StockMap 2-week forecast & tracked accuracy